Easton Quick Ratio from 2010 to 2026
Easton Pharmaceutica's Quick Ratio is decreasing with stable movements from year to year. Quick Ratio is estimated to finish at 0.67 this year. Quick Ratio is a measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities. View All Fundamentals
Check out the analysis of Easton Pharmaceutica Correlation against competitors. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.
Quick Ratio | First Reported 2010-12-31 | Previous Quarter 0.62 | Current Value 0.67 | Quarterly Volatility 1.34909979 |
Check Easton Pharmaceutica financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Easton Pharmaceutica's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 161.2 K or Research Development of 179.8 K, as well as many indicators such as Price To Sales Ratio of 0.94, Dividend Yield of 0.0 or PTB Ratio of 0.13. Easton financial statements analysis is a perfect complement when working with Easton Pharmaceutica Valuation or Volatility modules.
Easton | Quick Ratio | Build AI portfolio with Easton Stock |
The Quick Ratio trend for Easton Pharmaceutica offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Easton Pharmaceutica is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Easton Pharmaceutica's Quick Ratio Growth Pattern
Below is the plot of the Quick Ratio of Easton Pharmaceutica over the last few years. It is a measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities. Easton Pharmaceutica's Quick Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Easton Pharmaceutica's overall financial position and show how it may be relating to other accounts over time.
| Quick Ratio | 10 Years Trend |
|
Quick Ratio |
| Timeline |
Easton Quick Ratio Regression Statistics
| Arithmetic Mean | 0.87 | |
| Geometric Mean | 0.50 | |
| Coefficient Of Variation | 154.49 | |
| Mean Deviation | 0.70 | |
| Median | 0.62 | |
| Standard Deviation | 1.35 | |
| Sample Variance | 1.82 | |
| Range | 5.7881 | |
| R-Value | (0.13) | |
| Mean Square Error | 1.91 | |
| R-Squared | 0.02 | |
| Significance | 0.62 | |
| Slope | (0.03) | |
| Total Sum of Squares | 29.12 |
Easton Quick Ratio History
About Easton Pharmaceutica Financial Statements
Investors use fundamental indicators, such as Easton Pharmaceutica's Quick Ratio, to determine how well the company is positioned to perform in the future. Although Easton Pharmaceutica's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Quick Ratio | 0.62 | 0.67 |
Currently Active Assets on Macroaxis
When determining whether Easton Pharmaceutica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Easton Pharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Easton Pharmaceutica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Easton Pharmaceutica Stock:Check out the analysis of Easton Pharmaceutica Correlation against competitors. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is there potential for Pharmaceuticals market expansion? Will Easton introduce new products? Factors like these will boost the valuation of Easton Pharmaceutica. Projected growth potential of Easton fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Easton Pharmaceutica's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Easton Pharmaceutica should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Easton Pharmaceutica's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.